168 related articles for article (PubMed ID: 31797692)
41. Oligo(Lactic Acid)
Tam YT; Repp L; Ma ZX; Feltenberger JB; Kwon GS
Pharm Res; 2019 Mar; 36(5):70. PubMed ID: 30888509
[TBL] [Abstract][Full Text] [Related]
42. Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12).
Sader HS; Farrell DJ; Castanheira M; Flamm RK; Jones RN
J Antimicrob Chemother; 2014 Oct; 69(10):2713-22. PubMed ID: 24917579
[TBL] [Abstract][Full Text] [Related]
43. Poly(ethylene glycol)-block-poly(2-methyl-2-benzoxycarbonyl-propylene carbonate) micelles for rapamycin delivery: in vitro characterization and biodistribution.
Lu W; Li F; Mahato RI
J Pharm Sci; 2011 Jun; 100(6):2418-29. PubMed ID: 21264854
[TBL] [Abstract][Full Text] [Related]
44. Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013-2015).
Pfaller MA; Shortridge D; Sader HS; Castanheira M; Flamm RK
Int J Antimicrob Agents; 2018 Feb; 51(2):181-189. PubMed ID: 28993143
[TBL] [Abstract][Full Text] [Related]
45. In vitro activity of piperacillin/tazobactam and other broad-spectrum antibiotics against bacteria from hospitalised patients in the British Isles.
Livermore DM; Mushtaq S; James D; Potz N; Walker RA; Charlett A; Warburton F; Johnson AP; Warner M; Henwood CJ
Int J Antimicrob Agents; 2003 Jul; 22(1):14-27. PubMed ID: 12842324
[TBL] [Abstract][Full Text] [Related]
46. Facile green synthesis of baicalein fabricated gold nanoparticles and their antibiofilm activity against Pseudomonas aeruginosa PAO1.
Rajkumari J; Busi S; Vasu AC; Reddy P
Microb Pathog; 2017 Jun; 107():261-269. PubMed ID: 28377235
[TBL] [Abstract][Full Text] [Related]
47. Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: Preparation, pharmacokinetics and distribution in vivo.
Song Z; Feng R; Sun M; Guo C; Gao Y; Li L; Zhai G
J Colloid Interface Sci; 2011 Feb; 354(1):116-23. PubMed ID: 21044788
[TBL] [Abstract][Full Text] [Related]
48. A novel cabazitaxel-loaded polymeric micelle system with superior in vitro stability and long blood circulation time.
Han X; Chen D; Sun J; Zhou J; Li D; Gong F; Shen Y
J Biomater Sci Polym Ed; 2016; 27(7):626-42. PubMed ID: 26914063
[TBL] [Abstract][Full Text] [Related]
49. Activity of piperacillin/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-kill.
Burgess DS; Hastings RW
Diagn Microbiol Infect Dis; 2000 Sep; 38(1):37-41. PubMed ID: 11025182
[TBL] [Abstract][Full Text] [Related]
50. pH-sensitive and folic acid-targeted MPEG-PHIS/FA-PEG-VE mixed micelles for the delivery of PTX-VE and their antitumor activity.
Di Y; Li T; Zhu Z; Chen F; Jia L; Liu W; Gai X; Wang Y; Pan W; Yang X
Int J Nanomedicine; 2017; 12():5863-5877. PubMed ID: 28860753
[TBL] [Abstract][Full Text] [Related]
51.
Goodlet KJ; Nicolau DP; Nailor MD
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
[TBL] [Abstract][Full Text] [Related]
52. pH-induced micelle formation of poly(histidine-co-phenylalanine)-block-poly(ethylene glycol) in aqueous media.
Kim GM; Bae YH; Jo WH
Macromol Biosci; 2005 Nov; 5(11):1118-24. PubMed ID: 16245269
[TBL] [Abstract][Full Text] [Related]
53. On the synthesis of mucus permeating nanocarriers.
Bourganis V; Karamanidou T; Samaridou E; Karidi K; Kammona O; Kiparissides C
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):239-49. PubMed ID: 25661586
[TBL] [Abstract][Full Text] [Related]
54. Cyclic RGDyK conjugation facilitates intracellular drug delivery of polymeric micelles to integrin-overexpressing tumor cells and neovasculature.
Yin J; Li Z; Yang T; Wang J; Zhang X; Zhang Q
J Drug Target; 2011 Jan; 19(1):25-36. PubMed ID: 20233083
[TBL] [Abstract][Full Text] [Related]
55. Comparison of antibiotic susceptibility and plasmid content, between biofilm producing and non-producing clinical isolates of Pseudomonas aeruginosa.
Delissalde F; Amábile-Cuevas CF
Int J Antimicrob Agents; 2004 Oct; 24(4):405-8. PubMed ID: 15380270
[TBL] [Abstract][Full Text] [Related]
56. HPMA-based polymeric micelles for curcumin solubilization and inhibition of cancer cell growth.
Naksuriya O; Shi Y; van Nostrum CF; Anuchapreeda S; Hennink WE; Okonogi S
Eur J Pharm Biopharm; 2015 Aug; 94():501-12. PubMed ID: 26134273
[TBL] [Abstract][Full Text] [Related]
57. Polymeric micelles and nanoemulsions as drug carriers: Therapeutic efficacy, toxicity, and drug resistance.
Gupta R; Shea J; Scafe C; Shurlygina A; Rapoport N
J Control Release; 2015 Aug; 212():70-7. PubMed ID: 26091919
[TBL] [Abstract][Full Text] [Related]
58. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Zhao C; Xie W; Zhang W; Ye Z; Wu H
Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
[TBL] [Abstract][Full Text] [Related]
59. Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015.
Castanheira M; Duncan LR; Mendes RE; Sader HS; Shortridge D
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263073
[TBL] [Abstract][Full Text] [Related]
60. N-Boc-histidine-capped PLGA-PEG-PLGA as a smart polymer for drug delivery sensitive to tumor extracellular pH.
Chang G; Li C; Lu W; Ding J
Macromol Biosci; 2010 Oct; 10(10):1248-56. PubMed ID: 20593367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
